IBBQ
IBBQ
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are...
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 GILD | Gilead Sciences, Inc. | 7.55% | 36.66K | $5.15M |
 AMGN | Amgen Inc. | 7.24% | 14.07K | $4.94M |
 VRTX | Vertex Pharmaceuticals Incorporated | 7.16% | 10.99K | $4.88M |
 REGN | Regeneron Pharmaceuticals, Inc. | 6.11% | 5.52K | $4.17M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 3.50% | 7.04K | $2.39M |
 INSM | Insmed Incorporated | 2.58% | 11.45K | $1.76M |
 RVMD | Revolution Medicines, Inc. | 2.27% | 10.52K | $1.55M |
 BIIB | Biogen Inc. | 2.05% | 7.80K | $1.40M |
 UTHR | United Therapeutics Corporation | 1.98% | 2.33K | $1.35M |
 ARGX | argenx SE | 1.82% | 1.50K | $1.24M |
 RPRX | Royalty Pharma plc | 1.63% | 22.75K | $1.11M |
 MRNA | Moderna, Inc. | 1.63% | 20.97K | $1.11M |
 ROIV | Roivant Sciences Ltd. | 1.62% | 38.01K | $1.11M |
 ILMN | Illumina, Inc. | 1.55% | 8.12K | $1.06M |
 INCY | Incyte Corporation | 1.51% | 10.57K | $1.03M |
 SMMT | Summit Therapeutics Inc. | 1.26% | 41.17K | $858.50K |
 VTRS | Viatris Inc. | 1.25% | 61.13K | $850.39K |
 ASND | Ascendis Pharma A/S | 1.20% | 3.28K | $818.73K |
 BBIO | BridgeBio Pharma, Inc. | 1.18% | 10.29K | $802.29K |
 MEDP | Medpace Holdings, Inc. | 1.14% | 1.50K | $780.00K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
United Kingdom
Netherlands
France
Ireland
Denmark
Germany
Canada
Switzerland
Singapore
Jersey
Iceland
Spain
Cayman Islands
Australia
China
Israel
Belgium.svg)
Taiwan (Province of China)SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States United Kingdom Netherlands France Ireland Denmark Germany Canada Switzerland Singapore Jersey Iceland Spain Cayman Islands Australia China Israel Belgium Taiwan (Province of China)Holdings (Top 20)
GILD
Gilead Sciences, Inc.
AMGN
Amgen Inc.
VRTX
Vertex Pharmaceuticals Incorporated
REGN
Regeneron Pharmaceuticals, Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
INSM
Insmed Incorporated
RVMD
Revolution Medicines, Inc.
BIIB
Biogen Inc.
UTHR
United Therapeutics Corporation
ARGX
argenx SE
RPRX
Royalty Pharma plc
MRNA
Moderna, Inc.
ROIV
Roivant Sciences Ltd.
ILMN
Illumina, Inc.
INCY
Incyte Corporation
SMMT
Summit Therapeutics Inc.
VTRS
Viatris Inc.
ASND
Ascendis Pharma A/S
BBIO
BridgeBio Pharma, Inc.
MEDP
Medpace Holdings, Inc.